Page last updated: 2024-08-16

su 4984 and pyrroles

su 4984 has been researched along with pyrroles in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hirth, P; Hubbard, SR; McMahon, G; Mohammadi, M; Schlessinger, J; Sun, L; Tang, C; Yeh, BK	1
Elbaum, D; Lydon, NB; Toledo, LM	1
Carter, E; Longley, BJ; Ma, Y; McMahon, G	1

Reviews

2 review(s) available for su 4984 and pyrroles

Article	Year
The structure-based design of ATP-site directed protein kinase inhibitors. Current medicinal chemistry, 1999, Volume: 6, Issue:9 Topics: Adenosine Triphosphate; Adenylyl Imidodiphosphate; Anthraquinones; Binding Sites; Catalytic Domain; Cyclin-Dependent Kinases; Drug Design; Enzyme Inhibitors; Humans; Kinetin; Piperazines; Protein-Tyrosine Kinases; Purines; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Receptors, Growth Factor; Roscovitine; Staurosporine; Structure-Activity Relationship	1999
New approaches to therapy for mastocytosis. A case for treatment with kit kinase inhibitors. Hematology/oncology clinics of North America, 2000, Volume: 14, Issue:3 Topics: Amino Acid Substitution; Combined Modality Therapy; Drug Design; Enzyme Activation; Enzyme Inhibitors; Feasibility Studies; Humans; Indoles; Ligands; Mast Cells; Mastocytosis; Piperazines; Point Mutation; Proto-Oncogene Proteins c-kit; Proto-Oncogenes; Pyrroles; Stem Cell Factor	2000

Article

Year

The structure-based design of ATP-site directed protein kinase inhibitors.

Current medicinal chemistry, 1999, Volume: 6, Issue:9

Topics: Adenosine Triphosphate; Adenylyl Imidodiphosphate; Anthraquinones; Binding Sites; Catalytic Domain; Cyclin-Dependent Kinases; Drug Design; Enzyme Inhibitors; Humans; Kinetin; Piperazines; Protein-Tyrosine Kinases; Purines; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Receptors, Growth Factor; Roscovitine; Staurosporine; Structure-Activity Relationship

1999

New approaches to therapy for mastocytosis. A case for treatment with kit kinase inhibitors.

Hematology/oncology clinics of North America, 2000, Volume: 14, Issue:3

Topics: Amino Acid Substitution; Combined Modality Therapy; Drug Design; Enzyme Activation; Enzyme Inhibitors; Feasibility Studies; Humans; Indoles; Ligands; Mast Cells; Mastocytosis; Piperazines; Point Mutation; Proto-Oncogene Proteins c-kit; Proto-Oncogenes; Pyrroles; Stem Cell Factor

2000

Other Studies

1 other study(ies) available for su 4984 and pyrroles

Article	Year
Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors. Science (New York, N.Y.), 1997, May-09, Volume: 276, Issue:5314 Topics: 3T3 Cells; Adenosine Triphosphate; Amino Acid Sequence; Animals; Crystallography, X-Ray; Enzyme Inhibitors; ErbB Receptors; Hydrogen Bonding; Mice; Models, Molecular; Phosphorylation; Phosphotyrosine; Piperazines; Protein-Tyrosine Kinases; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 1; Receptor, Insulin; Receptors, Fibroblast Growth Factor; Receptors, Platelet-Derived Growth Factor	1997

Article

Year

Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors.

Science (New York, N.Y.), 1997, May-09, Volume: 276, Issue:5314

Topics: 3T3 Cells; Adenosine Triphosphate; Amino Acid Sequence; Animals; Crystallography, X-Ray; Enzyme Inhibitors; ErbB Receptors; Hydrogen Bonding; Mice; Models, Molecular; Phosphorylation; Phosphotyrosine; Piperazines; Protein-Tyrosine Kinases; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 1; Receptor, Insulin; Receptors, Fibroblast Growth Factor; Receptors, Platelet-Derived Growth Factor

1997